GlassScriptPhysician profile
James Anthony Torma
NPI 1659303543
$332.61
in general payments reported to CMS, 2019-2025
12 companies · $162 in 2025
The $162 reported for 2025 was more than what 76% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.83 · 2022: $16.89 · 2024: $129 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $291.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $68.60 | 2024-2025 | Wegovy, Ozempic |
| Boston Scientific Corporation | $44.53 | 2024-2025 | Mylux Patient Kit With Mobile Device, Watchman Flx |
| Abiomed | $40.62 | 2024-2025 | Impella |
| Chiesi USA, INC. | $35.13 | 2024-2025 | Kengreal |
| Janssen Pharmaceuticals, INC | $29.64 | 2024 | Xarelto |
| Ambu INC. | $20.78 | 2025 | |
| Medtronic, INC. | $20.76 | 2024 | Corevalve Evolut R |
| Astrazeneca Pharmaceuticals LP | $17.80 | 2025 | Farxiga |
| Merck Sharp & Dohme LLC | $16.89 | 2022 | |
| Novartis Pharmaceuticals Corporation | $14.03 | 2025 | |
| B. Braun Medical INC. | $12.13 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $11.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Torma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.